Home
|Insights
|Re. summary proceedings and biosimilar pharmaceuticals: "Biosimilars en Belgische octrooigeschillen (zoals) in kort geding: een geïnformeerd magistraat is meer waard," IRDI

PDF Link

Re. summary proceedings and biosimilar pharmaceuticals: "Biosimilars en Belgische octrooigeschillen (zoals) in kort geding: een geïnformeerd magistraat is meer waard," IRDI

Publication | 09.01.13

Attachments

Download Attachment
Biosimilars And Belgian Patent Disputes

Contacts

Jan-Diederik Lindemans
Partner
- Brussels
  - D | +32.2.282.1832
amxpbmRlbWFuc0Bjcm93ZWxsLmNvbQ==

Insights

Publication | 10.15.26

New York State Department of Financial Services Ramps Up Health Care Cybersecurity Enforcement With $2.25 Million Settlement

Publication | 10.12.26
The Liquidity Imperative: Opportunity and Risk in Next-Generation Collateral Enhancement
Publication | 09.29.26
Qatar’s Judicial Enforcement Law No. 4 of 2024: A Reminder of Qatar’s Landmark Reform
Publication | 09.28.26
States Are Leading the Way on AI Safety Regulation

View All Insights

Subscribe

to the latest insights from our team